Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care

Guest: Ashvini Keshavan, MRCP, PhD Very few patients in UK memory services receive an Alzheimer’s diagnosis supported by molecular testing, limiting timely access to emerging therapies. The ADAPT trial—which was funded by the Blood Biomarker Challenge, a multi-million-pound program supported by the Alzheimer's Society, Alzheimer's Research UK, and players of People's Postcode Lottery—aims to close this gap by evaluating the real-world integration of blood-based biomarkers into standard NHS memory care pathways. Join Dr. Ashvini Keshavan as she discusses how this approach may impact diagnostic accuracy, treatment access, and healthcare resource use across the UK. Dr. Keshavan is a Senior Clinical Research Fellow and Honorary Consultant Neurologist specializing in Alzheimer’s disease biomarkers at the University College London, and this topic was presented as a poster at the 2025 CTAD conference.

You can listen to Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care online on Radio and Podcast. Open the player on this page to stream the available audio.

Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care is an episode from NeuroFrontiers by ReachMD.

This episode is 00:04:30 long.

This episode was published on Dec 10, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.